XHYH Fees and Costs — BondBloxx USD High Yield Bond Healthcare Sector ETF

Data updated: 2026-06-26

The net expense ratio is 0.35%. There are no sales loads or redemption fees. In fiscal 2025 the fund paid $5K in broker commissions, 0.0131% of average net assets, and portfolio turnover was 27%.

XHYH Fees and Expenses

Annual operating expenses and sales charges of XHYH. Prospectus, as of February 28, 2026.

Annual operating expenses
Management fee0.35%
12b-1 fee0.00%
Other expenses0.00%
Gross expense ratio0.35%
Fee waiver—
Net expense ratio0.35%
Sales charges
Max front load—
Max deferred load—
Redemption fee—
Expense limitation in place (N-CEN)No
Fees waived or reduced during the yearNo
Waived fees subject to recoupmentNo

XHYH Costs Over Time

On $10,000 invested in XHYH, assuming 5% a year before costs, total costs come to $230 over 5 years, cutting the return by 0.38% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).

$10,000 investedSell after 1 yearSell after 3 yearsSell after 5 years
Value before costs$10,500$11,576$12,763
Fund expenses (net expense ratio 0.35%)$37$115$202
Trading costs (broker commissions)$1$4$8
Lost growth on money paid in costs$0$6$21
Total costs$38$126$230
Value after costs$10,462$11,451$12,533
Impact on return, per year0.38%0.38%0.38%

XHYH Trading Costs

Brokerage costs reported on SEC Form N-CEN for the fiscal year ending October 31, 2025.

  • Explicit cost rate (commissions ÷ average net assets): 0.0131%
  • Total broker commissions: $5K
  • Bought from dealers (principal trades, not a cost): —
  • Portfolio turnover (prospectus): 27%
  • Securities lending: none during the year

XHYH Agency Brokers

Commissions paid.

BrokerAmountShare
FIDELITY MANAGEMENT & RESEARCH COMPANY$5K100.00%

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.